Home
Name
ABT-546
Alternate Names
None
Abbreviations
None
Category
Chemotherapy
Subcategory
Cytostatic agent--enodthelin receptor antagonist
NSC Number
None
Primary Site
Other cancer
Histology
None
Remarks
As of March 2015, this drug has not received FDA approval and it is not in any clinical trials for use in treating cancers.
Coding
This drug should NOT be coded
